Back to Search Start Over

Neuregulin signaling pathway in smoking behavior

Authors :
Miina Ollikainen
Veikko Salomaa
Pamela A. F. Madden
Amanda B Zheutlin
Markus Perola
Sebastian Therman
Tyrone D. Cannon
Anu Loukola
Lili Milani
Samuli Ripatti
Tero Hiekkalinna
Richa Gupta
Liang He
Jaakko Kaprio
Beenish Qaiser
Tellervo Korhonen
School of Medicine / Public Health
Institute for Molecular Medicine Finland
University of Helsinki
Quantitative Genetics
Clinicum
Department of Public Health
Samuli Olli Ripatti / Principal Investigator
Biostatistics Helsinki
HUS Abdominal Center
Complex Disease Genetics
Epigenetics of Complex Diseases and Traits
Genetic Epidemiology
Source :
Translational Psychiatry
Publication Year :
2017
Publisher :
Springer Nature, 2017.

Abstract

Understanding molecular processes that link comorbid traits such as addictions and mental disorders can provide novel therapeutic targets. Neuregulin signaling pathway (NSP) has previously been implicated in schizophrenia, a neurodevelopmental disorder with high comorbidity to smoking. Using a Finnish twin family sample, we have previously detected association between nicotine dependence and ERBB4 (a neuregulin receptor), and linkage for smoking initiation at the ERBB4 locus on 2q33. Further, Neuregulin3 has recently been shown to associate with nicotine withdrawal in a behavioral mouse model. In this study, we scrutinized association and linkage between 15 036 common, low frequency and rare genetic variants in 10 NSP genes and phenotypes encompassing smoking and alcohol use. Using the Finnish twin family sample (N=1998 from 740 families), we detected 66 variants (representing 23 LD blocks) significantly associated (false discovery rate P<br />published version<br />peerReviewed

Details

Language :
English
Database :
OpenAIRE
Journal :
Translational Psychiatry
Accession number :
edsair.doi.dedup.....ed18c3135343b08018b984a8474fbc08